Literature DB >> 8254032

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model.

P Costelli1, N Carbó, L Tessitore, G J Bagby, F J Lopez-Soriano, J M Argilés, F M Baccino.   

Abstract

Rats bearing the Yoshida AH-130 ascites hepatoma showed enhanced fractional rates of protein degradation in gastrocnemius muscle, heart, and liver, while fractional synthesis rates were similar to those in non-tumor bearing rats. This hypercatabolic pattern was associated with marked perturbations of the hormonal homeostasis and presence of tumor necrosis factor in the circulation. The daily administration of a goat anti-murine TNF IgG to tumor-bearing rats decreased protein degradation rates in skeletal muscle, heart, and liver as compared with tumor-bearing rats receiving a nonimmune goat IgG. The anti-TNF treatment was also effective in attenuating early perturbations in insulin and corticosterone homeostasis. Although these results suggest that tumor necrosis factor plays a significant role in mediating the changes in protein turnover and hormone levels elicited by tumor growth, the inability of such treatment to prevent a reduction in body weight implies that other mediators or tumor-related events were also involved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254032      PMCID: PMC288478          DOI: 10.1172/JCI116897

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  43 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 2.  Cancer cachexia.

Authors:  A Theologides
Journal:  Cancer       Date:  1979-05       Impact factor: 6.860

3.  A comparison of methods for the measurement of protein turnover in vivo.

Authors:  M L MacDonald; S L Augustine; T L Burk; R W Swick
Journal:  Biochem J       Date:  1979-11-15       Impact factor: 3.857

4.  Comparison of in vitro cell cytotoxic assays for tumor necrosis factor.

Authors:  D A Flick; G E Gifford
Journal:  J Immunol Methods       Date:  1984-03-30       Impact factor: 2.303

Review 5.  Metabolic approaches to cancer cachexia.

Authors:  D H Lawson; A Richmond; D W Nixon; D Rudman
Journal:  Annu Rev Nutr       Date:  1982       Impact factor: 11.848

6.  Control of cell protein catabolism in rat liver. Effects of starvation and administration of cycloheximide.

Authors:  F M Baccino; L Tessitore; G Cecchini; M Messina; M F Zuretti; G Bonelli; L Gabriel; J S Amenta
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

7.  Inhibition of basal protein degradation in rat embryo fibroblasts by cycloheximide: correlation with activities of lysosomal proteases.

Authors:  J S Amenta; M J Sargus; F M Baccino
Journal:  J Cell Physiol       Date:  1978-12       Impact factor: 6.384

Review 8.  Cancer cachexia in man: a review.

Authors:  A J Strain
Journal:  Invest Cell Pathol       Date:  1979 Jul-Sep

9.  A rapid and convenient technique for measuring the rate of protein synthesis in tissues by injection of [3H]phenylalanine.

Authors:  P J Garlick; M A McNurlan; V R Preedy
Journal:  Biochem J       Date:  1980-11-15       Impact factor: 3.857

10.  Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor.

Authors:  S M Mahony; M J Tisdale
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

View more
  68 in total

1.  An intermediate dose of LCMV clone 13 causes prolonged morbidity that is maintained by CD4+ T cells.

Authors:  Andrew Stamm; Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  Virology       Date:  2012-02-04       Impact factor: 3.616

2.  Fenofibrate prevents skeletal muscle loss in mice with lung cancer.

Authors:  Marcus D Goncalves; Seo-Kyoung Hwang; Chantal Pauli; Charles J Murphy; Zhe Cheng; Benjamin D Hopkins; David Wu; Ryan M Loughran; Brooke M Emerling; Guoan Zhang; Douglas T Fearon; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

3.  Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer.

Authors:  M D Goncalves; S Taylor; D F Halpenny; E Schwitzer; S Gandelman; J Jackson; A Lukose; A J Plodkowski; K S Tan; M Dunphy; L W Jones; R J Downey
Journal:  Clin Radiol       Date:  2018-01-06       Impact factor: 2.350

4.  Nutritional treatment of cancer cachexia in rats. Use of a diet formulated with a crayfish enzymatic extract.

Authors:  Olga Cremades; Juan Parrado; María Jover; Laura Collantes de Terán; Juan Francisco Gutiérrez; Juan D Bautista Palomas
Journal:  Eur J Nutr       Date:  2007-08-04       Impact factor: 5.614

Review 5.  Impaired regeneration: A role for the muscle microenvironment in cancer cachexia.

Authors:  Erin E Talbert; Denis C Guttridge
Journal:  Semin Cell Dev Biol       Date:  2015-09-16       Impact factor: 7.727

6.  Amino acid uptake in skeletal muscle of rats bearing the Yoshida AH-130 ascites hepatoma.

Authors:  C García-Martínez; F J López-Soriano; J M Argilés
Journal:  Mol Cell Biochem       Date:  1995-07-05       Impact factor: 3.396

7.  Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial.

Authors:  J N Gordon; T M Trebble; R D Ellis; H D Duncan; T Johns; P M Goggin
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

8.  Metabolic effects of tumour necrosis factor-alpha on rat brown adipose tissue.

Authors:  J López-Soriano; J M Argilés; F J López-Soriano
Journal:  Mol Cell Biochem       Date:  1995-02-23       Impact factor: 3.396

9.  Inhibitory effect of tumor necrosis factor α on gluconeogenesis in perfused rat liver.

Authors:  Aline Franco da Rocha; Thaís Fernanda Liboni; Carolina Campos Lima Moreira; Daniele Romani Miksza; Camila Oliveira de Souza; Flaviane de Fatima Silva; Glaucia Regina Borba-Murad; Roberto Barbosa Bazotte; Helenir Medri de Souza
Journal:  Mol Cell Biochem       Date:  2012-12-09       Impact factor: 3.396

10.  Glutathione depletion impairs myogenic differentiation of murine skeletal muscle C2C12 cells through sustained NF-kappaB activation.

Authors:  Esther Ardite; Joan Albert Barbera; Josep Roca; Jose C Fernández-Checa
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.